Abstract
While antimicrobial peptides (AMPs) are well-known for their disruptive effects on bacterial membranes, the mechanism of many intracellular AMPs is still being elucidated. In the recent years, it has been demonstrated that the subclass of proline-rich AMPs (PrAMPs) can pass through the bacterial membrane and kill bacteria by inhibiting protein synthesis. PrAMPs are a product of the innate immune system and are secreted in response to bacterial infection. So farĀ PrAMPs have been identified in many arthropods, such as beetles, wasps, and flies, as well as some mammals, such as sheep, cows, and goats. PrAMPs show high potency against Gram-negative bacteria, while exhibiting low toxicity in eukaryotes, suggesting that they may represent a promising avenue for the development of future antimicrobial agents to combat the increase of multidrug-resistant bacterial pathogens. Structural and biochemical data have revealed the PrAMP binding sites on the ribosome as well as insight into their mechanisms of action. While the binding site of all so far investigated PrAMPs is situated within nascent polypeptide exit tunnel, the mechanism of action is distinct between class I and II PrAMPs. Specifically, class I PrAMPs, such as Bac7, Onc112, pyrrhocoricin, and metalnikowin, block the delivery of aa-tRNA by EF-Tu to the ribosomal A-site, whereas the class II PrAMPs, such as apidaecin 1b and Api137, act during translation termination and inhibit protein synthesis by trapping of release factors on the 70S ribosome following hydrolysis of the nascent polypeptide chain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Agerberth B, Lee JY, Bergman T, Carlquist M, Boman HG, Mutt V, Jornvall H (1991) Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem 202:849ā854
Asai T, Zaporojets D, Squires C, Squires CL (1999) An Escherichia coli strain with all chromosomal rRNA operons inactivated: complete exchange of rRNA genes between bacteria. Proc Natl Acad Sci U S A 96:1971ā1976
Benincasa M, Scocchi M, Podda E, Skerlavaj B, Dolzani L, Gennaro R (2004) Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates. Peptides 25:2055ā2061. https://doi.org/10.1016/j.peptides.2004.08.004
Berthold N et al (2013) Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens. Antimicrob Agents Chemother 57:402ā409. https://doi.org/10.1128/AAC.01923-12
Brogden KA (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat Rev Microbiol 3:238ā250. https://doi.org/10.1038/nrmicro1098
Bulet P et al (1993) A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J Biol Chem 268:14893ā14897
Casteels P, Tempst P (1994) Apidaecin-type peptide antibiotics function through a non-poreforming mechanism involving stereospecificity. Biochem Biophys Res Commun 199:339ā345. https://doi.org/10.1006/bbrc.1994.1234
Casteels P, Ampe C, Jacobs F, Vaeck M, Tempst P (1989) Apidaecins: antibacterial peptides from honeybees. EMBO J 8:2387ā2391
Casteels P et al (1990) Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera). Eur J Biochem 187:381ā386
Casteels-Josson K, Capaci T, Casteels P, Tempst P (1993) Apidaecin multipeptide precursor structure: a putative mechanism for amplification of the insect antibacterial response. EMBO J 12:1569ā1578
Castle M, Nazarian A, Yi SS, Tempst P (1999) Lethal effects of apidaecin on Escherichia coli involve sequential molecular interactions with diverse targets. J Biol Chem 274:32555ā32564
Chernysh S, Cociancich S, Briand JP, Hetru C, Bulet P (1996) The inducible antibacterial peptides of the Hemipteran insect Palomena prasina: identification of a unique family of prolinerich peptides and of a novel insect defensin. J Insect Physiol 42:81ā89. https://doi.org/10.1016/0022-1910(95)00085-2
Cociancich S et al (1994) Novel inducible antibacterial peptides from a hemipteran insect, the sap-sucking bug Pyrrhocoris apterus. Biochem J 300(Pt 2):567ā575
Florin T et al (2017) An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome. Nat Struct Mol Biol 24:752ā757. https://doi.org/10.1038/nsmb.3439
Frolova L et al (1999) Mutations in the highly conserved GGQ motif of class 1 polypeptide release factors abolish the ability of human eRF1 to trigger peptidyl-tRNA hydrolysis. RNA 5:1014ā1020
Gagnon MG, Roy RN, Lomakin IB, Florin T, Mankin AS, Steitz TA (2016) Structures of proline-rich peptides bound to the ribosome reveal a common mechanism of protein synthesis inhibition. Nucleic Acids Res 44:2439ā2450. https://doi.org/10.1093/nar/gkw018
Gennaro R, Skerlavaj B, Romeo D (1989) Purification, composition, and activity of two bactenecins, antibacterial peptides of bovine neutrophils. Infect Immun 57:3142ā3146
Graf M et al (2017) Proline-rich antimicrobial peptides targeting protein synthesis. Nat Prod Rep 34:702ā711. https://doi.org/10.1039/c7np00020k
Huttner KM, Lambeth MR, Burkin HR, Burkin DJ, Broad TE (1998) Localization and genomic organization of sheep antimicrobial peptide genes. Gene 206:85ā91
Knappe D et al (2010) Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens. J Med Chem 53:5240ā5247. https://doi.org/10.1021/jm100378b
Knappe D, Zahn M, Sauer U, Schiffer G, Strater N, Hoffmann R (2011) Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex. Chembiochem 12:874ā876. https://doi.org/10.1002/cbic.201000792
Knappe D, Adermann K, Hoffmann R (2015) Oncocin Onc72 is efficacious against antibiotic-susceptible Klebsiella pneumoniae ATCC 43816 in a murine thigh infection model. Biopolymers 104:707ā711. https://doi.org/10.1002/bip.22668
Krizsan A, Volke D, Weinert S, Strater N, Knappe D, Hoffmann R (2014) Insect-derived proline-rich antimicrobial peptides kill bacteria by inhibiting bacterial protein translation at the 70S ribosome. Angew Chem Int Ed Eng 53:12236ā12239. https://doi.org/10.1002/anie.201407145
Krizsan A, Prahl C, Goldbach T, Knappe D, Hoffmann R (2015) Short proline-rich antimicrobial peptides inhibit either the bacterial 70S ribosome or the assembly of its large 50S subunit. Chembiochem 16:2304ā2308. https://doi.org/10.1002/cbic.201500375
Lai Y, Gallo RL (2009) AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol 30:131ā141. https://doi.org/10.1016/j.it.2008.12.003
Mardirossian M, Grzela R, Giglione C, Meinnel T, Gennaro R, Mergaert P, Scocchi M (2014) The host antimicrobial peptide Bac71-35 binds to bacterial ribosomal proteins and inhibits protein synthesis. Chem Biol 21:1639ā1647. https://doi.org/10.1016/j.chembiol.2014.10.009
Mardirossian M et al (2018) The dolphin proline-rich antimicrobial peptide Tur1A inhibits protein synthesis by targeting the bacterial ribosome. Cell Chem Biol 25(5):530ā539. https://doi.org/10.1016/j.chembiol.2018.02.004
Mattiuzzo M, Bandiera A, Gennaro R, Benincasa M, Pacor S, Antcheva N, Scocchi M (2007) Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. Mol Microbiol 66:151ā163. https://doi.org/10.1111/j.1365-2958.2007.05903.x
Mora L, Heurgue-Hamard V, Champ S, Ehrenberg M, Kisselev LL, Buckingham RH (2003) The essential role of the invariant GGQ motif in the function and stability in vivo of bacterial release factors RF1 and RF2. Mol Microbiol 47:267ā275
Nissen P, Hansen J, Ban N, Moore PB, Steitz TA (2000) The structural basis of ribosome activity in peptide bond synthesis. Science 289:920ā930
Otvos L Jr (2002) The short proline-rich antibacterial peptide family. Cell Mol Life Sci 59:1138ā1150
Otvos L Jr et al (2000) Interaction between heat shock proteins and antimicrobial peptides. Biochemistry 39:14150ā14159
Peschel A, Sahl HG (2006) The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat Rev Microbiol 4:529ā536. https://doi.org/10.1038/nrmicro1441
Podda E, Benincasa M, Pacor S, Micali F, Mattiuzzo M, Gennaro R, Scocchi M (2006) Dual mode of action of Bac7, a proline-rich antibacterial peptide. Biochim Biophys Acta 1760:1732ā1740. https://doi.org/10.1016/j.bbagen.2006.09.006
RNAcentral (2017) RNAcentral: a comprehensive database of non-coding RNA sequences. Nucleic Acids Res 45:D128āD134. https://doi.org/10.1093/nar/gkw1008
Roy RN, Lomakin IB, Gagnon MG, Steitz TA (2015) The mechanism of inhibition of protein synthesis by the proline-rich peptide oncocin. Nat Struct Mol Biol 22:466ā469. https://doi.org/10.1038/nsmb.3031
Runti G et al (2013) Functional characterization of SbmA, a bacterial inner membrane transporter required for importing the antimicrobial peptide Bac7(1-35). J Bacteriol 195:5343ā5351. https://doi.org/10.1128/JB.00818-13
Sato NS, Hirabayashi N, Agmon I, Yonath A, Suzuki T (2006) Comprehensive genetic selection revealed essential bases in the peptidyl-transferase center. Proc Natl Acad Sci U S A 103:15386ā15391. https://doi.org/10.1073/pnas.0605970103
Schnapp D, Kemp GD, Smith VJ (1996) Purification and characterization of a proline-rich antibacterial peptide, with sequence similarity to bactenecin-7, from the haemocytes of the shore crab, Carcinus maenas. Eur J Biochem 240:532ā539
Schneider M, Dorn A (2001) Differential infectivity of two Pseudomonas species and the immune response in the milkweed bug, Oncopeltus fasciatus (Insecta: Hemiptera). J Invertebr Pathol 78:135ā140. https://doi.org/10.1006/jipa.2001.5054
Scocchi M, LĆ¼thy C, Decarli P, Mignogna G, Christen P, Gennaro R (2009) The proline-rich antibacterial peptide Bac7 binds to and inhibits in vitro the molecular chaperone DnaK. Int J Pept Res Ther 15:147ā155. https://doi.org/10.1007/s10989-009-9182-3
Scocchi M, Tossi A, Gennaro R (2011) Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action. Cell Mol Life Sci 68:2317ā2330. https://doi.org/10.1007/s00018-011-0721-7
Seefeldt AC et al (2015) The proline-rich antimicrobial peptide Onc112 inhibits translation by blocking and destabilizing the initiation complex. Nat Struct Mol Biol 22:470ā475. https://doi.org/10.1038/nsmb.3034
Seefeldt AC et al (2016) Structure of the mammalian antimicrobial peptide Bac7(1-16) bound within the exit tunnel of a bacterial ribosome. Nucleic Acids Res 44:2429ā2438. https://doi.org/10.1093/nar/gkv1545
Seit-Nebi A, Frolova L, Justesen J, Kisselev L (2001) Class-1 translation termination factors: invariant GGQ minidomain is essential for release activity and ribosome binding but not for stop codon recognition. Nucleic Acids Res 29:3982ā3987
Shamova O, Brogden KA, Zhao C, Nguyen T, Kokryakov VN, Lehrer RI (1999) Purification and properties of proline-rich antimicrobial peptides from sheep and goat leukocytes. Infect Immun 67:4106ā4111
Shao S, Murray J, Brown A, Taunton J, Ramakrishnan V, Hegde RS (2016) Decoding mammalian ribosome-mRNA states by translational GTPase complexes. Cell 167:1229ā1240.e1215. https://doi.org/10.1016/j.cell.2016.10.046
Shaw JJ, Green R (2007) Two distinct components of release factor function uncovered by nucleophile partitioning analysis. Mol Cell 28:458ā467. https://doi.org/10.1016/j.molcel.2007.09.007
Stensvag K, Haug T, Sperstad SV, Rekdal O, Indrevoll B, Styrvold OB (2008) Arasin 1, a proline-arginine-rich antimicrobial peptide isolated from the spider crab, Hyas araneus. Dev Comp Immunol 32:275ā285. https://doi.org/10.1016/j.dci.2007.06.002
Storici P, Zanetti M (1993) A cDNA derived from pig bone marrow cells predicts a sequence identical to the intestinal antibacterial peptide PR-39. Biochem Biophys Res Commun 196:1058ā1065. https://doi.org/10.1006/bbrc.1993.2358
Thompson J etĀ al (2001) Analysis of mutations at residues A2451 and G2447 of 23S rRNA in the peptidyltransferase active site of the 50S ribosomal subunit. Proc Natl Acad Sci U S A 98:9002ā9007
Voss NR, Gerstein M, Steitz TA, Moore PB (2006) The geometry of the ribosomal polypeptide exit tunnel. J Mol Biol 360:893ā906
Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27ā55. https://doi.org/10.1124/pr.55.1.2
Zahn M, Berthold N, Kieslich B, Knappe D, Hoffmann R, Strater N (2013) Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK. J Mol Biol 425:2463ā2479. https://doi.org/10.1016/j.jmb.2013.03.041
Zahn M, Kieslich B, Berthold N, Knappe D, Hoffmann R, Strater N (2014) Structural identification of DnaK binding sites within bovine and sheep bactenecin Bac7. Protein Pept Lett 21:407ā412
Zanetti M, Litteri L, Gennaro R, Horstmann H, Romeo D (1990) Bactenecins, defense polypeptides of bovine neutrophils, are generated from precursor molecules stored in the large granules. J Cell Biol 111:1363ā1371
Zanetti M, Litteri L, Griffiths G, Gennaro R, Romeo D (1991) Stimulus-induced maturation of probactenecins, precursors of neutrophil antimicrobial polypeptides. J Immunol 146:4295ā4300
Zanetti M, Del Sal G, Storici P, Schneider C, Romeo D (1993) The cDNA of the neutrophil antibiotic Bac5 predicts a pro-sequence homologous to a cysteine proteinase inhibitor that is common to other neutrophil antibiotics. J Biol Chem 268:522ā526
Zasloff M (2002) Antimicrobial peptides in health and disease. N Engl J Med 347:1199ā1200. https://doi.org/10.1056/NEJMe020106
Zavialov AV, Mora L, Buckingham RH, Ehrenberg M (2002) Release of peptide promoted by the GGQ motif of class 1 release factors regulates the GTPase activity of RF3. Mol Cell 10:789ā798
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Graf, M., Wilson, D.N. (2019). Intracellular Antimicrobial Peptides Targeting the Protein Synthesis Machinery. In: Matsuzaki, K. (eds) Antimicrobial Peptides. Advances in Experimental Medicine and Biology, vol 1117. Springer, Singapore. https://doi.org/10.1007/978-981-13-3588-4_6
Download citation
DOI: https://doi.org/10.1007/978-981-13-3588-4_6
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-3587-7
Online ISBN: 978-981-13-3588-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)